Solid Biosciences (SLDB) to Offer $85M in Common Stock

Solid Biosciences Inc., (Nasdaq: SLDB) announced that it has commenced an underwritten public offering of $85 million of shares of its common stock. All of the shares are being offered by Solid. In addition, Solid expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering on the same terms and conditions.

The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies, SVB Leerink and Piper Sandler are acting as joint book-running managers for the offering. Chardan is acting as lead manager for the offering.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• AssetMark Financial Holdings Inc. (AMK) Signs Definitive Agreement to be Acquired by GTCR
• Mr. Cooper Group Inc. (COOP) PT Raised to $87 at Jefferies